The India vaccine market was valued at INR 118.76 billion in 2023, driven by the high burden of infectious diseases, rising strategic collaborations, and increased focus on local vaccine production capabilities in the country. The market is expected to grow at a CAGR of 8.8% during the forecast period of 2025-2034, with the values likely to reach INR 278.53 billion by 2032.

Get a Free Sample Report with a Table of Contents: https://www.expertmarketresearch.com/reports/indian-vaccine-market/requestsample

India Vaccine Market Overview

The Indian vaccine market plays a pivotal role in global immunisation efforts. With a robust manufacturing base, India contributes significantly to vaccine production, accounting for approximately 60% of the global supply. The market encompasses a wide range of vaccines targeting infectious diseases, paediatric immunisations, and emerging diseases like COVID-19. Increasing government initiatives, including the Universal Immunisation Programme (UIP), and the presence of a strong public-private partnership model further bolster market development.

Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/indian-vaccine-market

India Vaccine Market Dynamics

1. Market Drivers

• High Disease Burden: India faces a significant burden of infectious diseases like tuberculosis, diphtheria, and hepatitis, driving demand for vaccines.
  
  
• Government Initiatives: Programs such as Mission Indradhanush have improved vaccine coverage, especially in rural areas.
  
  
• Technological Advancements: Innovation in vaccine delivery systems, such as needle-free technology, is enhancing adoption rates.
  
  
• Strategic Collaborations: Partnerships between local manufacturers and global pharma giants are accelerating vaccine accessibility and affordability.

2. Market Challenges

• Cold Chain Logistics: Maintaining a robust cold chain infrastructure remains a key challenge for vaccine distribution in remote areas.
  
  
• Vaccine Hesitancy: Misinformation and lack of awareness about immunisation benefits hinder market growth.
  
  
• Regulatory Hurdles: Stringent clinical trial and approval processes can delay vaccine launches.

3. Opportunities

• Focus on Exports: India is well-positioned to expand its vaccine exports to emerging markets in Africa and Southeast Asia.
  
  
• Customised Vaccines: Rising demand for region-specific vaccines, such as dengue and chikungunya, creates new growth avenues.
  
  
• Research and Development (R&D): Increased investment in mRNA vaccines and other next-generation technologies offers significant potential.

External India Vaccine Market Trends

• Rising Investment in Biologics: The Indian government and private firms are heavily investing in biologics to strengthen vaccine R&D capabilities.
  
  
• Global Health Partnerships: Collaborations with organisations like the WHO and GAVI ensure improved immunisation access in India.
  
  
• Focus on Pandemic Preparedness: The COVID-19 pandemic has underscored the importance of vaccine development, leading to a surge in funding and innovation for pandemic preparedness.

India Vaccine Market Segmentation

1. By Vaccine Type

• Preventive Vaccines: These include vaccines for polio, tuberculosis, and hepatitis.
• Therapeutic Vaccines: Primarily in development for diseases like cancer.

2. By Technology

• Live-Attenuated Vaccines: Widely used for measles and rotavirus.
• Inactivated Vaccines: Common for diseases like hepatitis and influenza.
• Recombinant Vaccines: Gaining traction due to safety and efficacy.

3. By End-User

• Public Health Programs: The largest consumer of vaccines, supported by government initiatives.
• Private Sector: Hospitals and clinics provide vaccines to urban and affluent populations.

4. By Region

• North India: Highest vaccine adoption due to better healthcare infrastructure.
• South India: Known for vaccine manufacturing hubs like Hyderabad.

India Vaccine Market Growth

The Indian vaccine market's growth is attributed to an increase in government funding, private investments, and public awareness campaigns. Companies are actively diversifying their portfolios to include innovative solutions like DNA vaccines and lipid nanoparticle-based mRNA vaccines. The growth of contract manufacturing and research organisations also plays a crucial role.

Recent Developments in the India Vaccine Market

• COVID-19 Vaccine Production: Companies like Bharat Biotech and the Serum Institute of India became global leaders in producing COVID-19 vaccines.
  
  
• New Launches: Introduction of vaccines for diseases like HPV and dengue strengthens the product pipeline.
  
  
• Collaborative Efforts: Partnerships between Indian manufacturers and global companies ensure cost-effective vaccine distribution.

India Vaccine Market Scope

The market scope extends beyond traditional vaccines to include novel platforms like RNA-based vaccines, cancer vaccines, and multi-disease formulations. The rising prevalence of lifestyle diseases has also led to increasing demand for therapeutic vaccines.

India Vaccine Market Analysis

The market is expected to maintain its growth trajectory due to favourable government policies, a rising population, and increased healthcare spending. The expansion of manufacturing capabilities and a focus on indigenous vaccine development will enhance India’s position as a global vaccine powerhouse.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the vaccine market, leading to:

• Increased investment in R&D for vaccine development.
• Strengthened cold chain logistics and distribution networks.
• Accelerated approval processes, paving the way for quicker vaccine launches.

Key Players in the India Vaccine Market

1. GlaxoSmithKline Plc

A global leader in vaccine production, GSK offers a wide range of vaccines targeting infectious diseases like rotavirus and meningitis.

2. Sanofi

Known for its innovative vaccine solutions, Sanofi has a strong presence in the Indian market with vaccines like Pentaxim and Shanchol.

3. Pfizer, Inc.

With a focus on advanced vaccine technologies, Pfizer contributes significantly to the Indian vaccine landscape with products like Prevenar 13.

(FAQs)

1. What is the current size of the India vaccine market?
The market was valued at INR 118.76 billion in 2023.

2. What are the major drivers of the India vaccine market?
High disease burden, government initiatives, and advancements in vaccine technology are key drivers.

3. Which companies dominate the India vaccine market?
GlaxoSmithKline Plc, Sanofi, and Pfizer, Inc. are among the key players.

4. What is the expected growth rate of the market?
The market is projected to grow at a CAGR of 8.8% during 2025-2034.

5. How has COVID-19 impacted the market?
The pandemic accelerated vaccine R&D, improved distribution networks, and highlighted the importance of local production capabilities.